News

Stocktwits on MSN41m

This Analyst Says Sarepta Lost Credibility By Exiting Arrowhead At A Loss, But Retail Sees Stock Hitting $30 By Next Week

H.C. Wainwright stated on Thursday that Sarepta Therapeutics’ (SRPT) recent divestiture in Arrowhead (ARWR) weakened its ...

Sarepta Sells Biotech Stake to Raise Cash as Elevidys Troubles Hit Home

The stock has been in free fall since safety issues derailed a gene therapy analysts had expected to achieve blockbuster ...

Sarepta sells Arrowhead shares as partnership, debt payments loom

Liquidating its stake in Arrowhead helps Sarepta cover a milestone payment and secure what one analyst described as ...